Suchergebnis | Hamburg Open Science

Facetten

23 Einträge gefunden

Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer.
2010 - Forschungsinformationssystem des UKE
Pelvic lymph node dissection in prostate cancer.
2009 - Forschungsinformationssystem des UKE
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.
2008 - Forschungsinformationssystem des UKE
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
2008 - Forschungsinformationssystem des UKE
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level
2008 - Forschungsinformationssystem des UKE
Development and external validation of an extended 10-core biopsy nomogram.
2007 - Forschungsinformationssystem des UKE
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
2007 - Forschungsinformationssystem des UKE
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
2007 - Forschungsinformationssystem des UKE
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Development and external validation of an extended repeat biopsy nomogram.
2007 - Forschungsinformationssystem des UKE
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
2007 - Forschungsinformationssystem des UKE
Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
2007 - Forschungsinformationssystem des UKE
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
2007 - Forschungsinformationssystem des UKE
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
2007 - Forschungsinformationssystem des UKE
Prostate volume and adverse prostate cancer features: fact not artifact.
2007 - Forschungsinformationssystem des UKE
Management of erectile dysfunction after radical prostatectomy in 2007.
2007 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer.

Pelvic lymph node dissection in prostate cancer.

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.

A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level

Development and external validation of an extended 10-core biopsy nomogram.

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.

Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.

A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.

Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.

Development and external validation of an extended repeat biopsy nomogram.

Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.

Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.

Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.

Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.

Prostate volume and adverse prostate cancer features: fact not artifact.

Management of erectile dysfunction after radical prostatectomy in 2007.